Back to News
Market Impact: 0.2
Does Collegium Pharmaceutical (COLL) Have the Potential to Rally 111.39% as Wall Street Analysts Expect?
Source: zacks.com
Analyst EstimatesAnalyst InsightsCompany Fundamentals
The consensus price target for Collegium Pharmaceutical (COLL) implies 111.4% upside. The article cautions that this metric has limited empirical effectiveness, while an upward trend in earnings estimate revisions may support near-term gains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
COLL0.20
More News
- Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues
- AI stock sell-off ramps up over debt-fueled data center spending fears: ‘Full-blown crisis of confidence'
- All the news about the iPhone Duo
- The Tesla Roadster should go into production in 2028, but don't get your hopes up
- Apple’s $1,999 iPhone Duo puts the company's status-symbol power to the test
- Trump says White House didn't order Starlink restrictions in Ukraine